BioSpace News Archive

Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today the retirement of Susan Berland, Executive Vice President and Chief Financial Officer (CFO), and the appointment of Herb Cross, an accomplished senior financial executive, as her successor.

Liht Cannabis Corp. (CSE: LIHT) (OTCQX: LIHTF) or the “Company”) is extremely proud to announce that each of its cultivation facilities in Las Vegas, Nevada have now achieved three organically grown certifications from EnvirOganic, Certified Kind and Clean Green.

In the United States, upwards of 30 million individuals are living with one of more than 7,000 identified rare and orphan diseases.

Back-to-Back Accreditations Further Solidify Soleo Health’s Commitment to High Quality Care Standards; Strengthen Industry Leadership Position

AR101 Associated with 70% Reduction in Allergic Reactions Due to Accidental Exposures That Required Treatment Compared to Placebo After Dose Escalation in PALISADE

Gracell addresses the issues of complex manufacture and high cost of cellular gene therapeutics

The conference presentation will be webcast live and may be accessed by visiting Horizon’s website at http://ir.horizon-pharma.com.

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced it will present 19 abstracts during the 2019 American Academy of Dermatology (AAD) Annual Meeting, March 1-5, in Washington, D.C., including new data from the psoriasis pivotal trials for risankizumab, an investigational interleukin-23 (IL-23) inhibitor.

Tru-D SmartUVC as part of a comprehensive infection reduction program

New details provide insights on the suitability of the sutureless aortic valve for future transcatheter solutions